Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > You guys do realize...

<< Previous

Bullboard Posts

Next >>

Comment by TheTerminator1on Jul 16, 2021 11:00am

106 Views

Post# 33559292

RE:You guys do realize...

Stop whining!

Trippedstocks wrote:
that was the 400 interim results/update right? "The recently selected dosage". So think about it, we have had 165 test subjects completed. 70 from the 210 and 95 from the next 190 (400 patent total) That's it. EUA on that? Not anytime soon.

50 sites? Wasn't that supposed to be aggressively pursued months ago? It has taken 7 months to get 400 completed. So 600 at end of September at the earliest at this enrollment rate. With vaccinations, and exclusion criteria, we are getting slim on available patients.